Hangzhou Alltest Biotech Co. Ltd. A (688606) — Cash Flow Reinvestment Rate
Hangzhou Alltest Biotech Co. Ltd. A (688606) has a Cash Flow Reinvestment Rate of 0.69x as of September 2025, reinvesting CN¥38.02 Million (capex CN¥38.02 Million ) from operating cash flow of CN¥55.21 Million. Explore 688606 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou Alltest Biotech Co. Ltd. A Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Hangzhou Alltest Biotech Co. Ltd. A across 10 annual periods. Also explore total assets of Hangzhou Alltest Biotech Co. Ltd. A for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hangzhou Alltest Biotech Co. Ltd. A (2016–2025)
Year-by-year capital reinvestment analysis for Hangzhou Alltest Biotech Co. Ltd. A. For live market cap and broader valuation context, see Hangzhou Alltest Biotech Co. Ltd. A stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.75x | CN¥567.47 Million | CN¥206.59 Million | CN¥219.10 Million | ▲ +96.4% |
| 2024 | 1.40x | CN¥460.75 Million | CN¥329.52 Million | CN¥220.65 Million | ▼ -96.3% |
| 2023 | 37.39x | CN¥926.03 Million | CN¥24.76 Million | CN¥533.49 Million | ▲ +3216.4% |
| 2022 | 1.13x | CN¥1.53 Billion | CN¥1.36 Billion | CN¥270.24 Million | ▲ +55.1% |
| 2021 | 0.73x | CN¥671.47 Million | CN¥923.87 Million | CN¥140.12 Million | ▲ +7.2% |
| 2020 | 0.68x | CN¥422.03 Million | CN¥622.72 Million | CN¥37.11 Million | ▲ +11.8% |
| 2019 | 0.61x | CN¥55.48 Million | CN¥91.53 Million | CN¥15.09 Million | ▼ -67.5% |
| 2018 | 1.86x | CN¥34.66 Million | CN¥18.60 Million | CN¥34.66 Million | ▼ -28.5% |
| 2017 | 2.61x | CN¥52.12 Million | CN¥19.99 Million | CN¥52.12 Million | ▲ +740.1% |
| 2016 | 0.31x | CN¥2.08 Million | CN¥6.72 Million | CN¥2.08 Million | — |